Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Corticosteroid Regimens for Treatment of Acute and Chronic Graft Versus Host Disease (GvHD) After Allogenic Stem Cell Transplantation." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434522/all/images/tooltip-triangle.png. Accessed 06 May 2024.
Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434522/all/images/tooltip-triangle.png. Accessed May 6, 2024.
Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434522/all/images/tooltip-triangle.png
Corticosteroid Regimens for Treatment of Acute and Chronic Graft Versus Host Disease (GvHD) After Allogenic Stem Cell Transplantation [Internet]. In: Cochrane Abstracts. [cited 2024 May 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434522/all/images/tooltip-triangle.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation
ID - 434522
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434522/all/images/tooltip-triangle.png
DB - Evidence Central
DP - Unbound Medicine
ER -